Position in GLUE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$28,495,207
+$11,364,639 QoQ
Shares Held
1,177,488
+13.1% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 193 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 91%
Shared 5%
None 4%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. GLUE ranks #51 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in GLUE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,495,207 | 1,177,488 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $17,130,568 | 1,041,372 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $8,911,992 | 568,367 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,684,468 | 632,182 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,021,208 | 448,162 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,220,272 | 262,990 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,004,987 | 144,811 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $738,146 | 139,273 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $575,053 | 153,758 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $512,358 | 72,675 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $137,368 | 24,313 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $178,590 | 37,284 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $255,285 | 37,268 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $290,317 | 37,268 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||